Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

DRD2 antagonist

DRUG CLASS:

DRD2 antagonist

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

dordaviprone (5)

chlorpromazine (3)

dordaviprone (5)

chlorpromazine (3)

›

H3.3K27M	Glioma	H3.3K27M	Glioma	dordaviprone Sensitive: B - Late Trials dordaviprone Sensitive : B	dordaviprone Sensitive: B - Late Trials dordaviprone Sensitive : B
H3.3K27M	Glioma	H3.3K27M	Glioma	bevacizumab + dordaviprone Sensitive: C3 – Early Trials bevacizumab + dordaviprone Sensitive : C3	bevacizumab + dordaviprone Sensitive: C3 – Early Trials bevacizumab + dordaviprone Sensitive : C3
MGMT unmethylation	Glioblastoma	MGMT unmethylation	Glioblastoma	chlorpromazine Sensitive: C3 – Early Trials chlorpromazine Sensitive : C3	chlorpromazine Sensitive: C3 – Early Trials chlorpromazine Sensitive : C3
EGFR overexpression	Glioblastoma	EGFR overexpression	Glioblastoma	dordaviprone Resistant: D – Preclinical dordaviprone Resistant : D	dordaviprone Resistant: D – Preclinical dordaviprone Resistant : D
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	darolutamide + dordaviprone Resistant: D – Preclinical darolutamide + dordaviprone Resistant : D	darolutamide + dordaviprone Resistant: D – Preclinical darolutamide + dordaviprone Resistant : D
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	zuclopenthixol Sensitive: D – Preclinical zuclopenthixol Sensitive : D	zuclopenthixol Sensitive: D – Preclinical zuclopenthixol Sensitive : D
TLR9 expression	Solid Tumor	TLR9 expression	Solid Tumor	fluphenazine Sensitive: D – Preclinical fluphenazine Sensitive : D	fluphenazine Sensitive: D – Preclinical fluphenazine Sensitive : D
EGFR T790M	Non Small Cell Lung Cancer	EGFR T790M	Non Small Cell Lung Cancer	chlorpromazine Sensitive: D – Preclinical chlorpromazine Sensitive : D	chlorpromazine Sensitive: D – Preclinical chlorpromazine Sensitive : D
EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR exon 19 deletion	Non Small Cell Lung Cancer	chlorpromazine Sensitive: D – Preclinical chlorpromazine Sensitive : D	chlorpromazine Sensitive: D – Preclinical chlorpromazine Sensitive : D
KRAS G12D	Pancreatic Cancer	KRAS G12D	Pancreatic Cancer	dordaviprone Sensitive: D – Preclinical dordaviprone Sensitive : D	dordaviprone Sensitive: D – Preclinical dordaviprone Sensitive : D